Email this article Validation of the Medical Research Council sum score (MRCss) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
- Authors: Suponeva N.A.1, Arestova A.S.1, Melnik E.A.1, Zimin A.A.1, Zaytsev A.B.2, Yakubu A.3, Sherbakova E.S.1, Yusupova D.G.1, Grishina D.A.1, Gnedovskaya E.V.1, Piradov M.A.1
-
Affiliations:
- Research Center of Neurology
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Columbia University
- Issue: Vol 13, No 1 (2023)
- Pages: 68-74
- Section: ORIGINAL REPORTS
- Published: 27.03.2023
- URL: https://nmb.abvpress.ru/jour/article/view/527
- DOI: https://doi.org/10.17650/2222-8721-2023-13-1-68-74
- ID: 527
Cite item
Full Text
Abstract
Background. The use of rating scales and questionnaires is essential in an evaluation of disease course, treatment response, the disability level and quality of life in patients with chronic inflammatory demyelinating polyneuropathy. The Medical Research Council (MRC) scale and its modification Medical Research Council sum score (MRCss) are widely used for measurement of motor deficit in patients with neuromuscular disorders. However, its usage is limited by the absence of the validated version for Russian-speaking patients.
Aim. To validate MRCss scale in patients with chronic inflammatory demyelinating polyneuropathy with development of a Russian version.
Materials and methods. We enrolled 50 patients with chronic inflammatory demyelinating polyneuropathy (25 with typical chronic inflammatory demyelinating polyneuropathy and 25 with Lewis–Sumner syndrome). At the first step we conducted linguocultural ratification according to the standard protocol. At the second step the psychometric parameters were evaluated, such as reliability, validity and sensitivity.
Results. The developed Russian version of MRCss scale demonstrated the high level of reliability, validity and sensitivity.
Conclusion. As a result, we developed a validated Russian version of MRCss scale, recommended for clinical practice and research.
About the authors
N. A. Suponeva
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0003-3956-6362
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationA. S. Arestova
Research Center of Neurology
Author for correspondence.
Email: rizvanova.alina@gmail.com
ORCID iD: 0000-0002-9890-3552
Alina Safovna Arestova,
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationE. A. Melnik
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0001-5436-836X
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationA. A. Zimin
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0002-9226-2870
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationA. B. Zaytsev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
ORCID iD: 0000-0003-3774-3070
Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationA. Yakubu
Columbia University
Email: fake@neicon.ru
ORCID iD: 0000-0001-5434-4966
116th Street and Broadway, New York 10027
United StatesE. S. Sherbakova
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0002-1706-089X
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationD. G. Yusupova
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0002-5826-9112
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationD. A. Grishina
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0002-7924-3405
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationE. V. Gnedovskaya
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0001-6026-3388
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationM. A. Piradov
Research Center of Neurology
Email: fake@neicon.ru
ORCID iD: 0000-0002-6338-0392
80 Volokolamskoe Shosse, Моscow 125367
Russian FederationReferences
- Medical Research Council. Aids to the examination of the peripheral nervous system. HM Stationery Office, 1976. P. 70.
- Kleyweg R.P., Van der Meche F.G.A., Meulstee J. Treatment of Guillain–Barré syndrome with high-dose gammaglobulin. Neurology 1988;38(10):1639. doi: 10.1212/WNL.38.10.1639
- Kleyweg R.P., Van Der Meché F.G.A., Schmitz P.I.M. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 1991;14(11):1103–9. doi: 10.1002/mus.880141111
- Merkies I.S.J., Schmitz P.I.M., van der Meché F.G.A. et al. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72(5):596–601. doi: 10.1136/jnnp.72.5.596
- Novik A.A., Ionova T.I. The manual for the quality-of-life evaluation in medicine. Moscow: ZAO “Olma Media Grupp”, 2007. 320 p. (In Russ.)
- Guillemin F., Bombardier C., Beaton D. Recommendations for the cross-cultural adaptation of health status measures. J Clin Epidemiol 1993;46(12):1417–32. doi: 10.1016/08954356(93)90142-n
- Belova A.N. Scales, tests and questionnaires in neurology and neurosurgery. Moscow: Prakticheskaya meditsina, 2018. 696 p. (In Russ.)
- Kadam P., Bhalerao S. Sample size calculation. Int J Ayurveda Res 2010;1(1):55. doi: 10.4103/0974-7788.59946
- Fargeot G., Maisonobe T., Psimaras D. et al. Comparison of Lewis–Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre. Eur J Neurol 2020;27(3):522–8. doi: 10.1111/ene.14101
Supplementary files
